SCHEMBL7366299

SCHEMBL7366299

NC(=NCl)Nc1cncc2cc(S(=O)(=O)N(CC(=O)OC(=O)C(F)(F)F)Cc3cccc(Cl)c3)ccc12

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLAU P00749 1/20 0.38
TAS2R14 Q9NYV8 2/20 0.37
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 1/20 0.36
CTSL P07711 1/20 0.35
CTSS P25774 1/20 0.35
DAGLA Q9Y4D2 2/20 0.34
CXCR3 P49682 4/20 0.33
MEP1B Q16820 1/20 0.33
RORC P51449 1/20 0.33
MMP1 P03956 2/20 0.32
MMP2 P08253 2/20 0.32
MMP9 P14780 2/20 0.32
MMP8 P22894 2/20 0.32
MMP13 P45452 2/20 0.32
CYP2D6 P10635 1/20 0.32
PTGER2 P43116 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7363430 0.93 PLAU (0.42) PLAUMAPTSMN1; SMN2LMNANPSR1
SCHEMBL7371411 0.88 MAPT (0.39) PLAUTAS2R14MAPTSMN1; SMN2LMNA
SCHEMBL7448814 0.86 SMN1; SMN2 (0.36) PLAUTAS2R14MAPTSMN1; SMN2LMNA
SCHEMBL7371684 0.85 ALDH1A1 (0.37) TAS2R14MAPTSMN1; SMN2LMNA
SCHEMBL7378754 0.83 PLAU (0.41) PLAUMAPTSMN1; SMN2LMNANPSR1
SCHEMBL7049646 0.81 PLAU (0.43) PLAUMAPTSMN1; SMN2LMNAMMP1
SCHEMBL7371892 0.81 TAS2R14 (0.40) PLAUTAS2R14MAPTSMN1; SMN2LMNA
SCHEMBL7378343 0.79 PDE4A (0.41) PLAUCXCR3MMP1MMP2MMP9
SCHEMBL6434442 0.79 PLAU (0.49) PLAUTAS2R14MAPTSMN1; SMN2LMNA
SCHEMBL7379322 0.79 DAGLA (0.45) PLAUTAS2R14MAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242120-A2 COMBINATIONS OF GROWTH FACTORS AND I:UPA OR I:MMP FOR THE TREATMENT OF DAMAGED TISSUE Pfizer Limited (GB) 2002-09-25 EP disclosed
WO-2001049309-A2 COMBINATIONS OF GROWTH FACTORS AND I: UPA OR I: MMP FOR THE TREATMENT OF DAMAGED TISSUE PFIZER LIMITED (GB) 2001-07-12 WO disclosed
EP-1077945-A1 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2001-02-28 EP disclosed
WO-2000005214-A2 ISOQUINOLINES AS UROKINASE INHIBITORS PFIZER INC. (US) 2000-02-03 WO disclosed